Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...

Dr. Reddy's Laboratories Ltd. closed 21.99% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...

Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, ...

Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...

The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...

The stock market experienced declines on March 12, with Dr. Reddy’s Laboratories and others reaching yearly lows due to US ...

Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.

Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...

Dr. Reddy's Laboratories Ltd. closed 22.18% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

In this article, we are going to take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against other best weight loss drug stocks to buy according to analysts. Most people have ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...